As of December 2024 Galectin Therapeutics has a market cap of $0.13 Billion USD. This makes Galectin Therapeutics the world's 8629th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 17th, 2024 the market cap of Galectin Therapeutics was reported to be: